Latest News

Is digital disruption of heart disease markets on the horizon?

Is digital disruption of heart disease markets on the horizon?

Allergan to acquire US medical technology company Zeltiq for $2.47bn

Allergan to acquire US medical technology company Zeltiq for $2.47bn

Natural Cycles fertility tracking app approved for contraception

Natural Cycles fertility tracking app approved for contraception

BTG launches DC Bead LUMI for liver cancer patients in Canada

BTG International has launched a next-generation treatment option, DC Bead LUMI, for cancer patients in Canada, marking its first worldwide market...

BTG launches DC Bead LUMI for liver cancer patients in Canada

Deals this week: Incyte Corporation, Orexigen Therapeutics Ireland, Mitsubishi Tanabe Pharma Corporation

US-based biopharmaceutical company Incyte Corporation has entered a distribution agreement for the commercialisation of its drug named Iclusig (ponatinib) in Greece with GENESIS...

Deals this week: Incyte Corporation, Orexigen Therapeutics Ireland, Mitsubishi Tanabe Pharma Corporation

M&As this week: CiToxLAB, Sichuan Kelun Pharma

French-based pre-clinical services provider CiToxLAB Group has announced that it has acquired a pre-clinical contract research company known as...

M&As this week: CiToxLAB, Sichuan Kelun Pharma

Haiti launches cholera vaccination campaign

Haiti has launched an emergency cholera vaccination campaign, under which more than 800,000 affected by Hurricane Matthew last month will be...

Haiti launches cholera vaccination campaign

University of Adelaide researchers test drug that promises to prevent pre-term birth

Researchers at the University of Adelaide have conducted a successful drug test that shows early promises of preventing pre-term...

University of Adelaide researchers test drug that promises to prevent pre-term birth

Teva receives approval for generic Tribenzor in US

Teva Pharmaceutical Industries has secured approval for generic Tribenzor (olmesartan medoxomil, amlodipine and hydrochlorothiazide) tablets in the US and is in the last stages of launch preparation....

Teva receives approval for generic Tribenzor in US

MHRA grants US patients with one form of blood cancer access to investigational medicine

The Medicines Healthcare Products and Regulatory Agency (MHRA) has granted US-based patients with one form of blood cancer access to the investigational medicine, nivolumab, through the...

MHRA grants US patients with one form of blood cancer access to investigational medicine

NICE recommends treatment with 60mg of ticagrelor in post-heart attack patients

AstraZeneca has announced that National Institute of Health and Care Excellence (NICE) has published a Final Appraisal Determination (FAD) recommending 60mg of ticagrelor with aspirin...

NICE recommends treatment with 60mg of ticagrelor in post-heart attack patients

M&As this week: Canopy Growth Corporation, Novogen, Karo Pharma

Canadian cannabis company Canopy Growth Corporation has completed the acquisition of medical cannabis company Vert...

M&As this week: Canopy Growth Corporation, Novogen, Karo Pharma

Deals this week: Asymchem Laboratories, Xbrane Biopharma, Biohaven Pharmaceutical Holding Company

Chinese-based contract manufacturing company Asymchem Laboratories has announced the issue of shares of its common stock in an initial public offering...

Deals this week: Asymchem Laboratories, Xbrane Biopharma, Biohaven Pharmaceutical Holding Company

UK team of health experts deployed to help control global disease outbreaks

A UK team of health experts comprising clinicians, scientists and academicians will be deployed to respond to requests from countries worldwide to help control disease outbreaks within 48 hours....

UK team of health experts deployed to help control global disease outbreaks

Novartis LEE011 receives FDA Priority Review for first-line treatment of HR+ / HER2- advanced breast cancer

The US Food and Drug Administration (FDA) has accepted Novartis' New Drug Application (NDA) for filing and granted Priority Review for LEE011 (ribociclib) as first-line treatment of...

Novartis LEE011 receives FDA Priority Review for first-line treatment of HR+ / HER2- advanced breast cancer

Medivir to sell BioPhausia to Karo Pharma

Medivir has entered into an agreement to sell its subsidiary BioPhausia (Nordic Brands) to Karo Pharma for Skr908m ($100.9m)....

Medivir to sell BioPhausia to Karo Pharma

M&As this week: Evotec AG, Shandong Jincheng Pharmaceutical, I’rom Group

Evotec has entered an agreement to acquire Cyprotex for a consideration of...

M&As this week: Evotec AG, Shandong Jincheng Pharmaceutical, I’rom Group

Deals this week: Nordic Nanovector, Myriad RBM, Relief Therapeutics

Nordic Nanovector and Heidelberg Pharma GmbH have entered a research agreement to develop novel treatment for...

Deals this week: Nordic Nanovector, Myriad RBM, Relief Therapeutics

M&As this week: Chengdu Kanghong Pharmaceutical Group, Cachet Pharmaceutical, Antegrin Therapeutics, Indalo Therapeutics

Chinese pharmaceutical company Chengdu Kanghong Pharmaceutical Group plans to increase its stake in a pharmaceutical unit in Chengdu for a consideration of $10.8...

M&As this week: Chengdu Kanghong Pharmaceutical Group, Cachet Pharmaceutical, Antegrin Therapeutics, Indalo Therapeutics

Report: Colombian pharmaceutical market to grow at CAGR of 7.3%

The Colombian pharmaceutical market will grow at a compound annual growth rate (CAGR) of 7.3% to surpass $7 billion in value by 2020, says a report by...

Report: Colombian pharmaceutical market to grow at CAGR of 7.3%

Deals this week: Accurexa, Perlara PBC, Myovant Sciences

Accurexa and StemImmune have entered a co-development agreement to develop stem-cell-mediated immunotherapy for...

Deals this week: Accurexa, Perlara PBC, Myovant Sciences
cachename:Newscachekey:rd-137342983_989685772_rd-1665407042_1857678299_rd-488908060_1460672566_ap1460672566_1857678299_1483048220